Spray Dried Dispersions: Performance, Manufacturing and Stability
About This Webcast
Unlock the full potential of poorly soluble compounds with Spray Dried Dispersions (SDDs). This webinar will explore key relationships between molecular properties, formulation strategies, and manufacturing performance—covering everything from in vitro testing and physical stability to critical spray drying and tableting parameters. Topics include: Overview of molecular property landscape and relevance to technology Guidance maps and structure-formulation relationships In vitro testing rationale and connection to biomodels Physical stability models Spray drying process overview and critical process parameters Tableting process overview and critical process parameters Case studies
Speakers
David Vodak
Chief Science Officer , Bend Bioscience
David has worked in the pharmaceutical field for over 20 years in Research and Development of drug delivery technologies. He has over 40 scientific and industry publications as well as over 20 patent and patent applications related to drug delivery via various modalities. Dr. Vodak is currently the Chief Scientific Officer of Bend Bioscience. After a post-doctoral research fellowship at the Scripps Research Institute in San Diego CA, working on self-assembling cyclic peptides, David joined Bend Research in Oregon where he worked on Spray-Dried Dispersion technology and bioavailability enhancement as well as other various particle engineering technologies, including nasal/pulmonary and non-invasive delivery of biologics. During his tenure with the organization, which eventually became part of Lonza, David led R&D in North America for the Dosage Form Solutions division before taking the position of Global Head of R&D for Small Molecules. David Vodak holds a PhD in Material Science from The University of Michigan, Ann Arbor.
Ashwin Venkatakrishnan
Drug Product Formulation & Process Engineer , Bend Bioscience
Ashwin Venkatakrishnan is a Drug Product Formulation and Process Engineer at Bend Bioscience, where he contributes to the advancement of robust, enabled formulations across the clinical development lifecycle. With a strong foundation in chemical engineering, Ashwin applies his specialized expertise in pharmaceutical formulation and process development to drive innovative solutions in both immediate and modified release drug product design. At Bend Bioscience, his work primarily focuses on the R&D-scale manufacture of spray-dried dispersion intermediates and final dosage forms. His technical scope includes spray drying, blending, dry granulation, compression, and coating, supporting both formulation feasibility studies and clinical manufacturing readiness. Ashwin plays a pivotal role in translating early formulation feasibility studies into clinically relevant manufacturing strategies, helping accelerate client programs from bench to clinic. Ashwin holds a Master of Science Degree in Chemical Engineering from Purdue University.
Tim Wright
Editor-in-Chief , Contract Pharma
Tim Wright is the editor of Contract Pharma magazine, which is a trade publication serving thousands of pharma and biopharma outsourcing professionals. He has been editor at Rodman Media since 2006. Prior to his position at Contract Pharma, he was an editor at Coatings World and Nonwovens Industry publications. Tim has a B.A. from Montclair State University in New Jersey where he studied English literature and journalism.